JP2018513216A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018513216A5 JP2018513216A5 JP2018505578A JP2018505578A JP2018513216A5 JP 2018513216 A5 JP2018513216 A5 JP 2018513216A5 JP 2018505578 A JP2018505578 A JP 2018505578A JP 2018505578 A JP2018505578 A JP 2018505578A JP 2018513216 A5 JP2018513216 A5 JP 2018513216A5
- Authority
- JP
- Japan
- Prior art keywords
- car
- medicine
- antigen receptor
- cells
- medicament according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562147793P | 2015-04-15 | 2015-04-15 | |
| US62/147,793 | 2015-04-15 | ||
| PCT/US2016/027582 WO2016168493A1 (en) | 2015-04-15 | 2016-04-14 | Hepatic arterial infusion of car-t cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018513216A JP2018513216A (ja) | 2018-05-24 |
| JP2018513216A5 true JP2018513216A5 (https=) | 2019-05-23 |
Family
ID=57126310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018505578A Pending JP2018513216A (ja) | 2015-04-15 | 2016-04-14 | Ｃａｒ−ｔ細胞の肝動脈注入 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10471098B2 (https=) |
| EP (1) | EP3283083A4 (https=) |
| JP (1) | JP2018513216A (https=) |
| KR (1) | KR20180021364A (https=) |
| CN (1) | CN108135937A (https=) |
| AR (1) | AR104296A1 (https=) |
| AU (1) | AU2016248090A1 (https=) |
| CA (1) | CA2982603A1 (https=) |
| HK (1) | HK1251179A1 (https=) |
| IL (1) | IL255005A0 (https=) |
| MX (1) | MX2017013247A (https=) |
| TW (1) | TWI719019B (https=) |
| WO (1) | WO2016168493A1 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4230262A3 (en) | 2015-06-24 | 2023-11-22 | The Regents Of The University Of Michigan | Histotripsy therapy systems for the treatment of brain tissue |
| CN107056952A (zh) * | 2017-05-10 | 2017-08-18 | 常州市第人民医院 | Cea.car‑t及其制备与应用 |
| US20200215112A1 (en) * | 2017-08-09 | 2020-07-09 | Ctg Pharma Ltd. | Chimeric antigen receptor for her2/neu and t-cells expressing same |
| CA3080109A1 (en) | 2017-11-03 | 2019-05-09 | Sorrento Therapeutics, Inc. | Cd38-directed chimeric antigen receptor constructs |
| ES2982438T3 (es) * | 2017-11-30 | 2024-10-16 | Singapore Health Serv Pte Ltd | Un sistema y método para clasificar pacientes con cáncer en grupos de tratamiento contra el cáncer adecuados y compuestos para tratar al paciente |
| AU2019231315A1 (en) * | 2018-03-09 | 2020-09-17 | Vivasor, Inc. | Dimeric antigen receptors (DAR) |
| CA3107383A1 (en) * | 2018-07-23 | 2020-01-30 | Magenta Therapeutics, Inc. | Use of anti-cd5 antibody drug conjugate (adc) in allogeneic cell therapy |
| IL311860A (en) * | 2018-08-02 | 2024-06-01 | Kite Pharma Inc | Treatment with receptor-antigen chimeric kinetics of T cell expansion and their uses |
| WO2020046766A1 (en) * | 2018-08-26 | 2020-03-05 | Oaiscell Biotechnologies | Method for treating glioblastoma |
| AU2019337603B2 (en) * | 2018-09-13 | 2026-03-05 | Nkarta, Inc. | Natural killer cell compositions and immunotherapy methods for treating tumors |
| CN113286552B (zh) | 2018-11-28 | 2025-05-02 | 希斯托索尼克斯公司 | 组织摧毁术系统及方法 |
| EP3773918A4 (en) | 2019-03-05 | 2022-01-05 | Nkarta, Inc. | CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY |
| EP3799881A1 (en) | 2019-10-04 | 2021-04-07 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Single domain antibodies specifically binding globo - series glycans |
| CA3162755A1 (en) * | 2019-11-25 | 2021-06-03 | Kyoto University | T-cell master cell bank |
| WO2021155026A1 (en) * | 2020-01-28 | 2021-08-05 | The Regents Of The University Of Michigan | Systems and methods for histotripsy immunosensitization |
| JP2023530477A (ja) | 2020-06-18 | 2023-07-18 | ヒストソニックス，インコーポレーテッド | 組織破砕音響／患者結合システムおよび方法 |
| EP4204084A4 (en) | 2020-08-27 | 2024-10-09 | The Regents Of The University Of Michigan | ULTRASONIC TRANSDUCER WITH TRANSMIT-RECEIVE CAPABILITY FOR HISTOTRIPSY |
| CA3196273A1 (en) * | 2020-09-22 | 2022-03-31 | Trisalus Life Sciences, Inc. | Cancer therapy using toll-like receptor agonists |
| CN116685330A (zh) * | 2020-09-22 | 2023-09-01 | 特萨乐斯生命科学公司 | 使用toll样受体激动剂的癌症疗法 |
| AR124414A1 (es) | 2020-12-18 | 2023-03-22 | Century Therapeutics Inc | Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable |
| US20240066125A1 (en) * | 2021-02-09 | 2024-02-29 | Obi Pharma, Inc. | Globo series antigens-binding chimeric antigen receptors and uses thereof |
| EP4351718A4 (en) | 2021-06-07 | 2025-03-26 | The Regents of The University of Michigan | MINIMALLY INVASIVE HISTOTRIPSY METHODS AND SYSTEMS |
| IL308943A (en) | 2021-06-07 | 2024-01-01 | Univ Michigan Regents | All-inclusive ultrasound systems and methods that include histotripsy |
| AU2023366591A1 (en) | 2022-10-28 | 2025-04-24 | Histosonics, Inc. | Histotripsy systems and methods |
| WO2024221001A2 (en) | 2023-04-20 | 2024-10-24 | Histosonics, Inc. | Histotripsy systems and associated methods including user interfaces and workflows for treatment planning and therapy |
| WO2025144964A2 (en) * | 2023-12-29 | 2025-07-03 | AffyImmune Therapeutics Inc. | Novel car constructs and methods of treatment |
| WO2026052782A1 (en) | 2024-09-06 | 2026-03-12 | Tacalyx Gmbh | Anti-globo h antibodies |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5874540A (en) * | 1994-10-05 | 1999-02-23 | Immunomedics, Inc. | CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies |
| US20020165360A1 (en) * | 2000-11-30 | 2002-11-07 | Junghans Richard P. | Chimeric effector cell receptors against carcinoembryonic antigen |
| WO2010085660A2 (en) * | 2009-01-23 | 2010-07-29 | Roger Williams Hospital | Viral vectors encoding multiple highly homologous non-viral polypeptides and the use of same |
| US9987308B2 (en) * | 2011-03-23 | 2018-06-05 | Fred Hutchinson Cancer Research Center | Method and compositions for cellular immunotherapy |
| CN103483452B (zh) * | 2012-06-12 | 2021-08-13 | 上海细胞治疗集团有限公司 | 双信号独立的嵌合抗原受体及其用途 |
| MX370148B (es) | 2012-10-02 | 2019-12-03 | Memorial Sloan Kettering Cancer Center | Composiciones y su uso para inmunoterapia. |
| CN113684185A (zh) | 2013-02-26 | 2021-11-23 | 纪念斯隆-凯特琳癌症中心 | 用于免疫疗法的组合物和方法 |
-
2016
- 2016-04-14 WO PCT/US2016/027582 patent/WO2016168493A1/en not_active Ceased
- 2016-04-14 KR KR1020177033070A patent/KR20180021364A/ko not_active Withdrawn
- 2016-04-14 TW TW105111666A patent/TWI719019B/zh not_active IP Right Cessation
- 2016-04-14 CA CA2982603A patent/CA2982603A1/en not_active Abandoned
- 2016-04-14 MX MX2017013247A patent/MX2017013247A/es unknown
- 2016-04-14 HK HK18110746.6A patent/HK1251179A1/zh unknown
- 2016-04-14 JP JP2018505578A patent/JP2018513216A/ja active Pending
- 2016-04-14 AU AU2016248090A patent/AU2016248090A1/en not_active Abandoned
- 2016-04-14 CN CN201680035380.XA patent/CN108135937A/zh active Pending
- 2016-04-14 US US15/099,370 patent/US10471098B2/en not_active Expired - Fee Related
- 2016-04-14 EP EP16780765.0A patent/EP3283083A4/en not_active Withdrawn
- 2016-04-15 AR ARP160101045A patent/AR104296A1/es unknown
-
2017
- 2017-10-15 IL IL255005A patent/IL255005A0/en unknown
-
2019
- 2019-10-09 US US16/597,798 patent/US20200138863A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018513216A5 (https=) | ||
| Alnefaie et al. | Chimeric antigen receptor T-cells: an overview of concepts, applications, limitations, and proposed solutions | |
| Pento | Monoclonal antibodies for the treatment of cancer | |
| CN113286879B (zh) | 用于细胞疗法之多样化抗原结合域、新颖平台及其他增强子 | |
| Harrer et al. | RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma | |
| Tai et al. | B cell maturation antigen (BCMA)-based immunotherapy for multiple myeloma | |
| Ma et al. | Advanced generation anti‐prostate specific membrane antigen designer T Cells for prostate cancer immunotherapy | |
| EP2990416B1 (en) | Universal chimeric antigen receptor expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders | |
| JP2017509342A5 (https=) | ||
| AU2025205213A1 (en) | Chimeric antigen receptor T cells targeting the tumor microenvironment | |
| JP2017537622A5 (https=) | ||
| EP3714941A1 (en) | Mage-a4 tcrs | |
| JP2017537627A5 (https=) | ||
| JP2017538401A5 (https=) | ||
| CN116970630A (zh) | 用于细胞治疗的组成型活性细胞因子受体 | |
| JP2020517658A5 (https=) | ||
| RU2017102769A (ru) | EGFRvIII СПЕЦИФИЧЕСКИЕ ХИМЕРНЫЕ АНТИГЕННЫЕ РЕЦЕПТОРЫ ДЛЯ ИММУНОТЕРАПИИ РАКА | |
| JP2020510704A5 (https=) | ||
| JP2017507936A5 (https=) | ||
| JP2016520074A5 (https=) | ||
| JP2018502060A5 (https=) | ||
| JP2016519933A5 (https=) | ||
| JP2017513478A5 (https=) | ||
| RU2016143155A (ru) | Cd33-специфические химерные антигенные рецепторы для иммунотерапии рака | |
| JP2018520094A5 (https=) |